Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil

International Journal of Dermatology

Volumn 46, Issue 7, 2007, Pages 679-686

  Borges, Saionara Zago ^a,b   Bakos, Lucio ^a   Cartell, André ^a   Wagner, Mario ^a   Agostini, Aventino ^a   Lersch, Elder ^a  

^a Hospital Universitário São Vicente de Paulo   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAZIL; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATHOLOGICAL ANATOMY; SEX DIFFERENCE; SKIN BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BRAZIL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS;

EID: 34447269659     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03037.x     Document Type: Article

References (98)

1. Riola RO, Garcia CM, Serrano S, et al. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol 2001; 17: 169-174.
2. Olivatto LO, ed. Oncologia Hoje. Rio de Janeiro: Instituto Nacional do Cancer, 1992: 5-28.
3. Coleman MP, Esteve J, Damiecki P, et al. Trends in Cancer Incidence and Mortality. Lyon, France: IARC Scientific Publications no. 121, 1993.
4. Parkin DM, Whelan SL, Ferlay J, et al., eds. Cancer Incidence in Five Continents, Vol VII. Lyon, France: International Agency for Reserarch on Cancer no. 143: 1997.
5. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surveys 1994; 19: 219-240.
6. Muir C, Waterhouse J, Mack T, et al., eds. Cancer Incidence in Five Continents, Vol V. World Health Organization, International Agency for Research on Cancer, International Association of Cancer Registries. Lyon, France: IARC Scientific Publications no. 88: 1987.
7. MacLennan R, Green AC, McLeod GRC, et al. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992; 84: 1427-1432.
8. MacKie RM, Hunter JAA, Aitchison TC, et al. Cutaneous malignant melanoma, Scotland, 1979-89. Lancet 1992; 339: 971-975.
9. Ries LA, Wingo PA, Miller DS, et al. The annual report to the Nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88: 2398-2424.
10. Ries LAG, Miller BA, Hankey BF. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. NIH Pub. No. 94-2789. Bethesda, MD: National Cancer Institute, 1994.
11. Desmond RA, Soong SJ. Epidemiology of malignant melanoma. Surg Clin N Am 2003; 83: 1-29.
12. Franceschi S, La Vecchia C, Luccini F, et al. The epidemiology of cutaneous malignant melanoma: Aetiology and European data. Eur J Cancer Prev 1991; 1: 9-22.
13. Elwood JM. Recent developments in melanoma epidemiology, 1993. Melanoma Res 1993; 3: 149-156.
14. Garland CF, Garland FK, Gorham ED. Rising trends in melanoma. An hypothesis concerning sunscreen effectiveness. Ann Epidemiol 1993; 3: 103-110.
15. Fitzpatrick TB, Kenet RO. Reducing mortality and morbidity of cutaneous melanoma: A 6-year plan. Identifying the population at risk. J Dermatol 1994; 21: 875-880.
16. Sober AJ, Lew RA, Koh HK, et al. Epidemiology of cutaneous melanoma. An update. Dermatol Clin 1991; 9: 617-629.
17. Lee JAH. Trends in melanoma. Incidence and mortality Clin Dermatol 1992; 10: 9-13.
18. Scotto J, Pitcher H, Lee JAH. Indications of future decreasing trends in skin melanoma mortality among whites in the United States. Int J Cancer 1991; 49: 490-497.
19. Collins JJ, Devine N. Period and cohort factors in the incidence of malignant melanoma in the state of Connecticut. Environ Health Perspect 1984; 56: 255-259.
20. Roush GC, Schymura MJ, Holford TR, et al. Time period compared to birth cohort in Connecticut incidence rates for twenty-five malignant neoplasms. J Natl Cancer Inst 1985; 74: 779-788.
21. Swerdlow AJ. International trends in cutaneous melanoma. Ann New York Acad Sciences 1990; 609: 235-251.
22. Thorn M, Bergstrom R, Adami H-O, et al. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am J Epidemiol 1990; 132: 1066-1077.
23. Venzon DJ, Mootgavkar SH. Cohort analysis of malignant melanoma in five countries. Am J Epidemiol 1984; 119: 62-70.
24. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa da incidência e mortalidade por câncer no Brasil. Brasília (DF); 1999.
25. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa da incidência e mortalidade por câncer no Brasil. Brasília (DF); 2002.
26. Peres MP. Incidência e prevalëncia de melanoma no Estado do Rio grande do Sul. An Bras Dermatol 1998; 73: 6-11.
27. Peres MP, Freitag F. Mortalidade por melanoma no Rio Grande do Sul. IV Conferência Nacional de Melanoma, São Paulo, 2001.
28. Salvatella N, Moragas JM. Monografias de dermatologia. 1989; 2.
29. Instituto Brasileiro de Geografia e Estatística (IBGE) - Censo 2000.
30. Clark WH, Bernardino EA. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-726.
31. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648.
32. McGovern VJ, Cochran AJ, Van Der Esch EP, et al. The classification of malignant melanoma, its histological reporting and registration: A revision of the 1972 Sydney classification. Pathol 1986; 18: 12-21.
33. McGoverns VJ, Mihm MC, Bailly C, et al. The classification malignant melanoma its histologic reporting. Cancer 1973; 32: 1446-1460.
34. Carli P, Borgognoni L, Biggeri A, et al. Incidence of cutaneous melanoma in the centre of Italy: Anatomic site distribution, histologic types and thickness of tumour invasion in a registry-based study. Melanoma Res 1994; 4: 385-390.
35. Cabrera R, Silva S, Diaz de Medina J, et al. Estudio clinico de 113 casos de melanoma maligno. Rev Med Chil 1994; 122: 900-906.
36. Kittler H, Binder M, Wolff K, et al. A ten-year analysis of demographic trends for cutaneous melanoma: Analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999). Wien Kin Wochenschr 2001; 113: 321-327.
37. Pondes S, Hunter JAA, White H, et al. Cutaneous malignant melanoma in south-east Scotland. Quart J Med, New Series L 1981; 197: 103-121.
38. English DR, Heenan PJ, Holman CDJ, et al. Melanoma in Western Australia in 1980-81: Incidence and characteristics of histological types. Pathol 1987; 19: 383-392.
39. Popescu NA, Beard CM, Treacy PJ, et al. Cutaneous Malignant Melanoma in Rochester, Minnesota: Trends in incidence and survivorship, 1950 through 1985. Mayo Clin Proc 1990; 65: 1293-1302.
40. Bakos L, Macmillan AL. Malignant melanoma in East Anglia, England. An II-year survey by site and type. Br J Dermatol 1973; 88: 551-556.
41. Bakos L. Melanomas malignos e etnia. An Bras Dermatol 1991; 66: 299-302.
42. Mackie RM, Watt D, Doherty V, et al. Malignant melanoma occurring in those aged under 30 in the west of Scotland 1979-1986: A study of incidence, clinical features, pathological features and survival. Br J Dermatol 1991; 124: 560-564.
43. Jelfs P, Giles G, Shugg D, et al. Cutaneous malignant melanoma in Australia. Med J Austral 1994; 161: 182-187.
44. Koh HK, Norton LA, Geller AC, et al. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. J Am Acad Dermatol 1996; 34: 971-978.
45. Bakos L, Gleisner AL, Dziekaniak K, et al. Sol e melanomas: Fatores de risco na população branca sulriograndense. An Bras Dermatol 1998; 73: 6-11.
46. Balzi D, Carli P, Giannotti B, et al. Skin Melanoma in Italy: A Population-based Study on Survival and Prognostic Factors. Eur J Cancer 1998; 34: 699-704.
47. Ponzio HA, Bernardi CDV, Favaretto AL, et al. Freqüência de melanoma maligno no Serviço de Dermatologia da ISCMPA/UFRGS. An Bras Dermatol 1998; 73: 6-11.
48. Saxe N, Hoffman M, Krige JE, et al. Malignant melanoma in Cape Town, South Africa. Br J Dermatol 1998; 138: 998-1002.
49. Jones WO, Harman CR, Alexander KT, et al. Incidence of Malignant Melanoma in Auckland, New Zealand: Highest Rates World. World J Surg 1999; 23: 732-735.
50. Zamolo G, Gruber F, Jonjic A, et al. A 20-year epidemiological study of cutaneous melanoma in the Rijeka district of Croatia. Clin Exp Dermatol 2000; 25: 77-81.
51. Garbe C, McLeod GRC, Buettner PG. Time trends of cutaneous melanoma in Queensland Australia and Central Europe. Cancer 2000; 89: 1269-1278.
52. D'Elia MB, Milani R, Martins PAM, et al. Melanoma maligno cutâneo: estudo retrospectivo de 1990 a 1999 no Hospital Nossa Senhora da Conceição em Porto Alegre-RS. Arq Cat Med 2000; 29: 119-121.
53. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and world-wide. Skin Pharmacol Appl Skin Physiol 2001; 14: 280-290.
54. Gordon LG, Lowry WS. The incidence and pathogenesis of invasive cutaneous malignant melanoma in Northern Ireland. Br J Cancer 1986; 53: 75-80.
55. Venegas LFP, Flores C, Blacher GG, et al. Melanoma maligno cutâneo no Rio Grande do Sul: Estudo de 101 casos. Rev Ass Med Brasil 1992; 38: 122-126.
56. Fernandes NC, Cardoso ICL, Maceira J, et al. Melanoma: Estudo retrospectivo de 47 casos. An Bras Dermatol 1996; 71: 381-385.
57. Tamir G, Milo Y, Rothem A, et al. Cutaneous malignant melanoma in young adults under age 30. Israel J Med Sci 1996; 32.
58. Ferreira CMM, Maceira JMP, Coelho JMCO. Análise imunohistopatológica, clínica e evolutiva dos melanomas. An Bras Dermatol 1997; 72: 117-126.
59. Lipsker DM, Hedelin G, Heid E, et al. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 1999; 135: 1451-1456.
60. Lapa MS, Guedes KF, Schalch FO, et al. Melanomas malignos cutâneos tratados no Hospital do Câncer de São Paulo. Estudo retrospectivo para avaliação de distribuição, fatores prognósticos e sobrevida. An Bras Dermatol 2002; 77: 313-320.
61. Horn-Ross P, Holly EA, Brown SR, et al. Temporal trends in the incidence of cutaneous malignant melanoma among Caucasians in the San Francisco Oakland MAS. Cancer Causes Control 1991; 2: 299-305.
62. Van Der Rhee HJ, Van Der Spek-Keijser LMT, Van Westering R, et al. Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980-95. Br J Derm 1999; 140: 463-467.
63. Vicenti M, Bergomi M, Borciani N, et al. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res 1986; 9: 97-103.
64. Balch CM, Murad TM, Soong SJ. Tumor thickness as a guide to surgical management in clinical stage 1 melanoma patients. Cancer 1979; 43: 883-890.
65. Davis NC. Malignant melanoma of the skin. Lancet 1966; 1: 91-93.
66. Baccard M, Havard S, Souques M, et al. Prospective study of the incidence of melanoma in the Paris region in 1994. Melanoma Res 1997; 7: 335-338.
67. Van der Spek-Keijer LM, Van der Rhee HJ, Toth G, et al. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol 1997; 136: 565-571.
68. Thorn M, Ponten F, Bergstrom R, et al. Trends in tumour characteristics and survival of malignant melanoma 1960-84: A population-based study in Sweden. Br J Cancer 1994; 70: 743-748.
69. Criado PR, Vasconcellos PRC, Sittart JAS, et al. Melanoma maligno cutâneo primário: Estudo reterospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo. Rev Ass Med Brasil 1999; 45: 157-162.
70. Oumeish OY. Epidemiology of primary cutaneous malignant melanoma in Jordan. Int J Dermatol 1997; 36: 113-115.
71. Carmichael VE, Wilson KS. Primary cutaneous malignant melanoma: Experience of the British Columbia Cancer Agency from 1972 to 1981. CJS 1992; 35: 589-597.
72. Pedlow PJ, Walsh MY, Patterson CC, et al. Cutaneous malignant melanoma in Northern Ireland. Br J Cancer 1997; 76: 124-126.
73. Marrett LD, Nguyen H, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 2001; 92: 457-462.
74. Hinds MW, Kolonel LN. Cutaneous malignant melanoma in Hawaii - An update. West J Med 1983; 138: 50-54.
75. Osterlind A. Epidemiology on malignant melanoma in Europe. Oncologica 1992; 5: 903-908.
76. Bakos L, Wagner M, Bakos R, et al. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol 2002; 41: 557-562.
77. Levi F, Franceschi S, Randimbison L, et al. Trends of skin cancer in the Canton of Vaud, 176-92. Br J Cancer 1995; 72: 1047-1053.
78. Balch CM, Soong SJ, Milton GW, et al. Changin trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer 1983; 52: 1748-1753.
79. McGregor SE, Birdsell JM, Grace MA, et al. Cutaneous malignant melanoma in Alberta: 1967-1976. Cancer 1983; 52: 755-761.
80. Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78: 276-280.
81. MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer 1998; 34: 3-6.
82. Pisani P, Parkin DM, Bray F, et al. Estimates of the world-wide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
83. Garbe C, Orfanos CE. Epidemiology of malignant melanoma in central Europe: Risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res 1992; XX: 285-294.
84. Giles GG, Amstrong BK, Burton RC, et al. Has mortality from melanoma stopped rising in Australia? Br Med J 1996; 312: 1121-1125.
85. Franceschi S, Bidoli E, Prati S, et al. Mortality from skin melanoma in Italy and Friuli-Venezia Guila Region, 1970-1989. Tumori 1994; 80: 251-256.
86. Mackie RM, Hole D, Hunter JAA, et al. Cutaneous malignant melanoma in Scotland: Incidence survival and mortality. Br Med J 1997; 315: 1117-1121.
87. Thorn M, Adami H-O, Bergstrom R, et al. Trends in survival from malignant melanoma: Remarkable improvement in 23 years. J Natl Cancer Inst 1989; 81: 611-617.
88. Cohn-Cedemark G, Mansson-Brahme E, Rutqvist LE, et al. Trends in mortality from malignant melanoma in Sweden, 1970-96. Cancer 2000; 89: 348-355.
89. Hall HI, Miller DR, Rodgers JD, et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999; 40: 35-42.
90. Weinstock MA. Do sunscreens increase or decrease melanoma risk: An epidemiologic investigation. J Invest Dermatol 1999; 4: 97-100.
91. Balzi D, Carli P, Geddes M. Malignant melanoma in Europe: Changes in mortality rates (1970-90) in European Community countries. Cancer Causes Control 1997; 8: 85-92.
92. Gellin GA, Kopf AW, Garfinkel L. Malignant melanoma: A controlled study of possibly associated factors. Arch Dermatol 1969; 99: 43-48.
93. Mackie RM, Hunter JA. Cutaneous malignant melanoma in Scotland. Br J Cancer 1982; 46: 75-80.
94. Davis NC. Malignant melanoma in Queensland. Curr Prob Surg 1976; 13: 1-63.
95. Mundth ED, Guralnick EA, Raker JW. Malignant melanoma: A review of 427 cases. Ann Surg 1965; 162: 15-18.
96. Rank BK, Marshall DR, McEwan DL, et al. Malignant melanoma. Presented at the Fifth Internaitonal Congress on Plastic and Reconstructive Surgery. Butterworth, Australia, 1971: 27.
97. Shaw JHF. Malignant melanoma in Auckland, New Zealand. Surgery Gyn Obst 1988; 166: 425-430.
98. Milton GW, Shaw HM, McCarthy WH. Resection margins for melanoma. Aust N Z J Surg 1985; 55: 225-228.